首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >High Pre-treatment Plasma D-Dimer Level as a Potential Prognostic Biomarker for Cervical Carcinoma
【24h】

High Pre-treatment Plasma D-Dimer Level as a Potential Prognostic Biomarker for Cervical Carcinoma

机译:高治疗血浆D-二聚体水平作为宫颈癌的潜在预后生物标志物

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background/Aim: We aimed to evaluate the prognostic significance of high pre-treatment plasma D-dimer levels in patients with cervical carcinoma (CC) after adjusting for venous thromboembolism. Patients and Methods: Relationships between the clinicopathological characteristics and the overall (OS) and progression-free (PFS) survival rates of patients with CC (N=129) were examined. Survival was calculated using the Kaplan-Meier method and prognostic indicators assessed using a Cox proportional hazards model. Results: A high pre-treatment plasma level of D-dimers, detected in 42.6% of cases (N=55), was associated with advanced tumour stage. In the multivariate analysis, high pre-treatment plasma D-dimer levels, tumour stage, histological type, and carcinoembryonic antigen (CEA) levels were identified as independent prognostic factors for OS, while tumour stage and CEA levels were identified as independent prognostic factors for PFS. Conclusion: A high pre-treatment plasma level of D-dimers represents an independent prognostic biomarker for CC that could assist in identifying high-risk populations for treatment decisions.
机译:背景/目的:我们旨在评估调整静脉血栓栓塞后,宫颈癌(CC)患者血浆中较高的治疗前血浆D-二聚体水平的预后意义。患者和方法:检查了CC病患(N = 129)的临床病理特征与总体(OS)和无进展(PFS)存活率之间的关系。使用Kaplan-Meier方法计算生存率,并使用Cox比例风险模型评估预后指标。结果:在42.6%的病例(N = 55)中检测到较高的D-二聚体血浆预处理水平与晚期肿瘤分期有关。在多变量分析中,治疗前血浆D-二聚体水平高,肿瘤分期,组织学类型和癌胚抗原(CEA)水平被确定为OS的独立预后因素,而肿瘤分期和CEA水平被确定为OS的独立预后因素。 PFS。结论:血浆D-二聚体的高治疗水平代表CC的独立预后生物标志物,可帮助识别高危人群以决定治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号